Bortezomib

본문 바로가기


Home > Product > Bortezomib
Selling leads
Bortezomib
Posting date : Jul 22, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Bortezomib is the first proteasome inhibitor approved by the US FDA for multiple myeloma (a type of blood cancer). Reversible 26S proteasome inhibitor, a bar-shaped multi-protein granule, exists in the nucleus and cytoplasm of all eukaryotic cells. Target the ubiquitin-proteasome pathway.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top